Viola Bonness, PhD
About Viola Bonness, PhD
Viola Bonness, PhD, is the Operations Portfolio Lead for Multiple Myeloma at Bristol Myers Squibb in Boudry, Neuchâtel, Switzerland. She has extensive experience in clinical research and operational management, having held various roles at Bristol Myers Squibb and other pharmaceutical companies.
Title
Viola Bonness, PhD, currently holds the position of Operations Portfolio Lead Multiple Myeloma at Bristol Myers Squibb. She began this role on November 1, 2020, and is based in Boudry, Neuchâtel, Switzerland.
Current Role at Bristol Myers Squibb
Viola Bonness is responsible for the global operational oversight of Medical Affairs and HEOR studies in Multiple Myeloma. This includes managing Phase 2-4, PASS, NIR, and ISR studies. Her expertise in overseeing multiple facets of clinical research is a significant asset to the company.
Professional Experience at Bristol Myers Squibb
Before her current role, Viola Bonness occupied several key positions at Bristol Myers Squibb over many years. She served as the GCH VOM Regional Outsourcing Lead Europe from 2015 to 2019 in Zug Area, Switzerland, and as Associate Director VOM NIR HEOR from 2014 to 2015 in Cham, Zug, Switzerland. She also worked as a Senior Clinical Protocol Manager from 2010 to 2014 and as a Clinical Protocol Manager from 2007 to 2010, both in Princeton, New Jersey, USA. Additionally, she held the role of Clinical Research Site Manager from 2003 to 2006 in Munich Area, Germany.
Early Career Positions
Viola Bonness started her career in clinical research with positions at notable pharmaceutical companies. She worked as a Clinical Research Associate at Amgen GmbH in Munich, Germany from 2001 to 2003. Prior to that, she served as a Field Based Monitor at Janssen-Cilag GmbH in Neuss, Germany from 1999 to 2001.
Education and Expertise
Viola Bonness holds a Ph.D. in Developmental Neurophysiology from University College London, UK, where she studied from 1995 to 1999. Her academic background provides a strong foundation for her extensive career in clinical research and medical affairs, particularly in the field of Multiple Myeloma.